OpenAI plans to open the floodgates to more adult uses of ChatGPT starting in December, according to a new post from CEO Sam Altman. The company announced that it would add parental controls and ...

OpenAI will soon lower restrictions on the content ChatGPT can produce, allowing the service to create "erotica" if users wish, CEO Sam Altman announced Tuesday. Altman noted that the new ...

Simon Thorne does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...

OpenAI will bring ‘erotica’ to ChatGPT once it rolls out age verification in December. OpenAI will bring ‘erotica’ to ChatGPT once it rolls out age verification in December. is a news writer who ...

More data is emerging supporting a sharp decline in the number of young adults identifying as transgender or non-binary. Last week, Fox News Digital reported on data shared by Eric Kaufman, a ...

OpenAI CEO Sam Altman announced in a post on X Tuesday the company will soon relax some of ChatGPT’s safety restrictions, allowing users to make the chatbot’s responses friendlier or more “human-like, ...

An upcoming version of popular chatbot ChatGPT will relax existing restrictions to allow more content, including erotica, for verified adult users, according to OpenAI chief Sam Altman. Altman said in ...

Do you ever find yourself jumping in to finish cleaning up your child’s toys even when you asked them to do it? Or perhaps instead it has become a reflex to stop tears to prevent that meltdown in ...

The signs were there but subtle. Dustin Chandler never did his homework. He was labeled lazy at school. It wasn’t until years later when his mother, now working at a pediatric clinic, watched him ...

We independently review everything we recommend. We may get paid to link out to retailer sites, and when you buy through our links, we may earn a commission. Learn more› By Sofia Sokolove Sofia ...

The U.S. Food and Drug Administration (FDA) has approved Gazyva® (obinutuzumab), developed by Genentech, as a treatment for adults with lupus nephritis (LN), also known as lupus-related kidney disease ...